Literature DB >> 23318416

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

J Stebbing1, A Filipović, G Giamas.   

Abstract

Claudins are integral structural and functional components of apical cell adhesions (tight junctions). Loss of such adhesions has been associated with malignant transformation, a process most often accompanied by a concomitant loss of claudin expression. A growing body of evidence reveals the highly contextual upregulation of claudin expression in certain cancer types, and moreover their relevance in promoting cancer cell invasion and metastatic progression. In this issue of Oncogene, Suh et al. reported on claudin-1 expression in hepatocellular carcinoma (HCC), including its role as a promoter of the epithelial-to-mesenchymal transition via the c-Abl/Raf/Ras/ERK signaling pathway. Considering the limited therapeutic options in HCC, evaluation of its role as a target merits further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318416     DOI: 10.1038/onc.2012.591

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  The effects of pleiotrophin in proliferative vitreoretinopathy.

Authors:  Xue Ding; Yujing Bai; Xuemei Zhu; Tianqi Li; Enzhong Jin; Lvzhen Huang; Wenzhen Yu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-12       Impact factor: 3.117

2.  HIFs enhance the migratory and neoplastic capacities of hepatocellular carcinoma cells by promoting EMT.

Authors:  Yang Liu; Yawei Liu; Xiaolu Yan; Yuan Xu; Fei Luo; Jing Ye; Han Yan; Xiaojun Yang; Xiaodan Huang; Jianping Zhang; Guozhong Ji
Journal:  Tumour Biol       Date:  2014-05-20

3.  Claudin-1 promotes TNF-α-induced epithelial-mesenchymal transition and migration in colorectal adenocarcinoma cells.

Authors:  Ajaz A Bhat; Rizwan Ahmad; SrijayaPrakash B Uppada; Amar B Singh; Punita Dhawan
Journal:  Exp Cell Res       Date:  2016-10-11       Impact factor: 3.905

4.  Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.

Authors:  Qinghong Dan; Yixuan Shi; Razieh Rabani; Shruthi Venugopal; Jenny Xiao; Shaista Anwer; Mei Ding; Pam Speight; Wanling Pan; R Todd Alexander; András Kapus; Katalin Szászi
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

Review 5.  Claudin proteins, outside-in signaling, and carcinogenesis.

Authors:  Amar B Singh; Srijayaprakash B Uppada; Punita Dhawan
Journal:  Pflugers Arch       Date:  2016-12-17       Impact factor: 3.657

6.  Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.

Authors:  Linfeng Xian; Pei Zhao; Xi Chen; Zhimin Wei; Hongxiang Ji; Jun Zhao; Wenbin Liu; Zishuai Li; Donghong Liu; Xue Han; Youwen Qian; Hui Dong; Xiong Zhou; Junyan Fan; Xiaoqiong Zhu; Jianhua Yin; Xiaojie Tan; Dongming Jiang; Hongping Yu; Guangwen Cao
Journal:  Cell Oncol (Dordr)       Date:  2022-08-29       Impact factor: 7.051

7.  Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-02-25       Impact factor: 2.303

8.  Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression.

Authors:  Ji-Ae Shin; Lee-Han Kim; Mi Heon Ryu; So-Young Choi; Bohwan Jin; WonWoo Lee; Yun Chan Jung; Chi-Hyun Ahn; Min-Hye Ahn; Kyoung-Ok Hong; Neeti Swarup; Kunal Chawla; Se Chan Kang; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Biol Toxicol       Date:  2021-03-04       Impact factor: 6.691

Review 9.  Cancer microenvironment and genomics: evolution in process.

Authors:  Stanley P Leong; Isaac P Witz; Orit Sagi-Assif; Sivan Izraely; Jonathan Sleeman; Brian Piening; Bernard A Fox; Carlo B Bifulco; Rachel Martini; Lisa Newman; Melissa Davis; Lauren M Sanders; David Haussler; Olena M Vaske; Marlys Witte
Journal:  Clin Exp Metastasis       Date:  2021-05-10       Impact factor: 5.150

10.  Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells.

Authors:  Shu-Ting Pan; Yiru Qin; Zhi-Wei Zhou; Zhi-Xu He; Xueji Zhang; Tianxin Yang; Yin-Xue Yang; Dong Wang; Shu-Feng Zhou; Jia-Xuan Qiu
Journal:  Drug Des Devel Ther       Date:  2015-10-05       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.